Name

SB249553

Alternate Names

SB 249553
SB-249553

Abbreviations

None

Category

Biologic therapy (BRM, immunotherapy)

Subcategory

Immunotherapy active

NSC Number

None

Primary Site

Lung
melanoma
skin cancer

Histology

None

Remarks

Phase II Recombinant Therapeutic Vaccine. GlaxoSmithKline.

Coding

This drug should be coded
Glossary